House Commerce Hearing May 3 To Kick Off User Fee Reauthorization Debate
Executive Summary
Drug approval times will be one topic of interest at the House Energy & Commerce/Health Subcommittee's May 3 hearing kicking off the user fee reauthorization process, Commerce Committee Majority Counsel Brent Del Monte told the Food & Drug Law Institute conference April 18 in Washington, D.C.
You may also be interested in...
House Commerce Committee Medicare Rx Group Revisiting Risk Distribution
The House Energy & Commerce Medicare reform working group is revisiting the distribution of financial risk between private health plans and the federal government under a Medicare prescription drug plan.
House Commerce Committee Medicare Rx Group Revisiting Risk Distribution
The House Energy & Commerce Medicare reform working group is revisiting the distribution of financial risk between private health plans and the federal government under a Medicare prescription drug plan.
FTC Spadework For Waxman/Hatch Reform Includes Survey, Patent Forum
The Federal Trade Commission is working on a schedule to collect background material for Congress on Waxman/Hatch reform by the beginning of 2002.